Am J Hematol 2020 Jun 29
A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON-EXT trial.
Related Questions
There are various formulations of intravenous iron; each with varying costs, test dose requirement, elemental dose, and number or time of infusions ne...
New comment by Medical Oncologist at Rush University Medical Center ( January 11, 2024)
Thank you, Dr. @Auerbach.